BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 837574)

  • 21. Diurnal change of serum androstenedione and testosterone and response to hCG and dexamethasone in women with polycystic ovaries, adrenal hyperandrogenism and unexplained hirsutism.
    Lisse K; Schürenkämper P; Friedrich W; Rutkowsky J
    Acta Endocrinol (Copenh); 1980 Feb; 93(2):216-22. PubMed ID: 7189630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian hyperthecosis in the adolescent patient.
    Wentz AC; Gutai JP; Jones GS; Migeon CJ
    J Pediatr; 1976 Mar; 88(3):488-93. PubMed ID: 1107505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian and adrenal vein steroids in patients with nonneoplastic hyperandrogenism: selective catheterization findings.
    Moltz L; Schwartz U; Sörensen R; Pickartz H; Hammerstein J
    Fertil Steril; 1984 Jul; 42(1):69-75. PubMed ID: 6233180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF; Serrano-Gotarredona J; García-Robles R; Sancho J; Varela C
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
    Toscano V; Balducci R; Bianchi P; Guglielmi R; Mangiantini A; Rossi FG; Colonna LM; Sciarra F
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hirsutism: implications, etiology, and management.
    Hatch R; Rosenfield RL; Kim MH; Tredway D
    Am J Obstet Gynecol; 1981 Aug; 140(7):815-30. PubMed ID: 7258262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral arterial and venous concentrations of various androgens in patients with and without hirsutism.
    Chang RJ; Abraham GE
    Obstet Gynecol; 1975 Nov; 46(5):549-50. PubMed ID: 127957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenal and ovarian vein androgen levels and laparoscopic findings in hirsute women.
    Northrop G; Archie JT; Patel SK; Wilbanks GD
    Am J Obstet Gynecol; 1975 May; 122(2):192-8. PubMed ID: 125544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androsterone sulfate: physiology and clinical significance in hirsute women.
    Zwicker H; Rittmaster RS
    J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal function in hirsutism I. Diurnal change and response of plasma androstenedione, testosterone, 17-hydroxyprogesterone, cortisol, LH and FSH to dexamethasone and 1/2 unit of ACTH.
    Givens JR; Andersen RN; Ragland JB; Wiser WL; Umstot ES
    J Clin Endocrinol Metab; 1975 Jun; 40(6):988-1000. PubMed ID: 166091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal abnormalities in idiopathic hirsutism.
    Moore A; Magee F; Cunningham S; Culliton M; McKenna TJ
    Clin Endocrinol (Oxf); 1983 Apr; 18(4):391-9. PubMed ID: 6307551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
    Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
    Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of overnight dexamethasone suppression on the adrenal androgen response to an oral glucose tolerance test in women with and without polycystic ovary syndrome.
    Buyalos RP; Geffner ME; Azziz R; Judd HL
    Hum Reprod; 1997 Jun; 12(6):1138-41. PubMed ID: 9221990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B; Mincey EK
    Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma sex hormone-binding globulin and androgen levels in the management of hirsute patients.
    Cunningham SK; Loughlin T; Culliton M; McKenna TJ
    Acta Endocrinol (Copenh); 1983 Nov; 104(3):365-71. PubMed ID: 6685420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Androgen production in women.
    Burger HG
    Fertil Steril; 2002 Apr; 77 Suppl 4():S3-5. PubMed ID: 12007895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of virilizing adrenal tumors in hirsute women.
    Derksen J; Nagesser SK; Meinders AE; Haak HR; van de Velde CJ
    N Engl J Med; 1994 Oct; 331(15):968-73. PubMed ID: 8084355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.
    Arlt W; Justl HG; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1928-34. PubMed ID: 9626121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.